ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer

Clinical trial NCT07425054 · RECRUITING

Trial details

NCT number: NCT07425054
Sponsor: Jennifer Dorth
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anal Cancer HPV-Related Carcinoma Squamous Cell Carcinoma of the Anus

Start date: 2026-06-19
Primary completion: 2029-01-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.